Recently, we and others have shown that resistance to anthracycline-based chemotherapy is almost universally based on the overexpression of Pgp in a clinically relevant mouse model of hereditary breast cancer [53,54,55,56,57]. The gene discussed is PGP; the disease is Hereditary breast cancer.